Oxford Nanopore Technologies (ONT) has reported a steady performance in its 2024 Half Year Interim Results, with CEO Gordon Sanghera confirming the company's alignment with ...

1 Day ONTTF 5.43% DJIA 0.72% S&P Mid Cap 400 1.71% Health Care/Life Sciences -0.83% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

At close: September 20 at 4:45 PM GMT+1 ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Sep. 18, 2024 — It is crucial for organisms to be able to control which genes are expressed in which cells and when. Naturally occurring chemical modifications of DNA-binding histone proteins ...

Oxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMO Oxford, UK – 18 September 2024: OXB (LSE:OXB), a quality and innovation-led cell and ...

Sep. 20, 2024 — A protein called STING, previously shown to control a pathway that contributes to antiviral signaling, also plays an important role in cellular stress clearance and cell survival ...

Spend Monday night with Rena for stories and great music from Asian communities.

The NHS is urging people to 'Act Now' in a sickle cell crisis. Oxford University Hospitals will be one of 18 pilot sites launching the new initiative this month. The 'Act Now' programme aims to ...